Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ingelman-Sundberg

Showing results (1-10 of 278) with videos related to

Pageof 28
Sort By:
Toxicology Letters|February 18, 1999
Functional consequences of polymorphism of xenobiotic metabolising enzymesM Ingelman-Sundberg
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001
Implications of polymorphic cytochrome p450-dependent drug metabolism for drug developmentM Ingelman-Sundberg
Biochimica Et Biophysica Acta|August 24, 1977
Phospholipids and detergents as effectors in the liver microsomal hydroxylase systemM Ingelman-Sundberg
Journal of Internal Medicine|October 30, 2014
Personalized medicine into the next generationM Ingelman-Sundberg
Biochimica Et Biophysica Acta|June 22, 1976
Specific reductive metabolism of steroid sulphates in rat liverM Ingelman-Sundberg
Journal of Internal Medicine|September 14, 2001
Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapyM Ingelman-Sundberg
The Pharmacogenomics Journal|October 20, 2004
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversityM Ingelman-Sundberg
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1997
The Gerhard Zbinden Memorial Lecture. Genetic polymorphism of drug metabolizing enzymes. Implications for toxicity of drugs and other xenobioticsM Ingelman-Sundberg
Drug Metabolism Reviews|May 21, 1999
Duplication, multiduplication, and amplification of genes encoding drug-metabolizing enzymes: evolutionary, toxicological, and clinical pharmacological aspectsM Ingelman-Sundberg
Toxicology Letters|April 27, 2001
Genetic variability in susceptibility and response to toxicantsM Ingelman-Sundberg
Pageof 28

Showing results (1-10 of 278) with videos related to

Sort By:
Pageof 28
Toxicology Letters|February 18, 1999
Functional consequences of polymorphism of xenobiotic metabolising enzymesM Ingelman-Sundberg
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001
Implications of polymorphic cytochrome p450-dependent drug metabolism for drug developmentM Ingelman-Sundberg
Biochimica Et Biophysica Acta|August 24, 1977
Phospholipids and detergents as effectors in the liver microsomal hydroxylase systemM Ingelman-Sundberg
Journal of Internal Medicine|October 30, 2014
Personalized medicine into the next generationM Ingelman-Sundberg
Biochimica Et Biophysica Acta|June 22, 1976
Specific reductive metabolism of steroid sulphates in rat liverM Ingelman-Sundberg
Journal of Internal Medicine|September 14, 2001
Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapyM Ingelman-Sundberg
The Pharmacogenomics Journal|October 20, 2004
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversityM Ingelman-Sundberg
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1997
The Gerhard Zbinden Memorial Lecture. Genetic polymorphism of drug metabolizing enzymes. Implications for toxicity of drugs and other xenobioticsM Ingelman-Sundberg
Drug Metabolism Reviews|May 21, 1999
Duplication, multiduplication, and amplification of genes encoding drug-metabolizing enzymes: evolutionary, toxicological, and clinical pharmacological aspectsM Ingelman-Sundberg
Toxicology Letters|April 27, 2001
Genetic variability in susceptibility and response to toxicantsM Ingelman-Sundberg
Pageof 28